Intracoronary epinephrine for contrast-medium-induced microvascular obstruction in a chronically hemodialyzed patient [1]

Cardiology

Volumn 103, Issue 4, 2005, Pages 196-198

  Lucreziotti, Stefano ^a   Sponzilli, Carlo ^b   Castini, Diego ^b   Di Domenico, Enrico ^b   Fiorentini, Cesare ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADRENALIN; CONTRAST MEDIUM; HEPARIN;

AGED; BLOOD ANALYSIS; BLOOD VESSEL OCCLUSION; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; HEMODIALYSIS; HUMAN; HYPERTENSION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; SINUS RHYTHM;

ADRENERGIC AGONISTS; AGED; CARDIOMYOPATHY, DILATED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VASOSPASM; EPINEPHRINE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; RENAL DIALYSIS; SHOCK; TRIIODOBENZOIC ACIDS;

EID: 21044432864     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085127     Document Type: Letter

References (11)

1. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, Bashore TM: Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 1989;110:119-124.
2. Skelding KA, Goldstein JA, Mehta L, Pica MC, O'Neill WW: Resolution of refractory no-reflow with intracoronary epinephrine. Cathet Cardiovasc Intervent 2002;57:305-309.
3. Epstein SE, Cannon RO III: Site of increased resistance to coronary flow in patients with angina pectoris and normal epicardial coronary arteries. J Am Coll Cardiol 1986;8:459-461.
4. Diver DJ, Bier JD, Ferreira PE, Sharaf BL, McCabe C, Thompson B, Chaitman B, Williams DO, Braunwald E: Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing. Am J Cardiol 1994;74:531-537.
5. Szczech LA, Chew DP, Coladonato JA, Reddan DN: The heart and the renal system; in Topol EJ (ed): Textbook of Cardiovascular Medicine. Philadelphia, Lippincott Williams & Wilkins, 2002, pp 797-814.
6. Esplugas E, Cequier A, Gomez-Hospital JA, Garcia Del Blanco B, Jara F: Comparative tolerability of contrast media used for coronary interventions. Drug Saf 2002;25:1079-1098.
7. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E: A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992;326:431-436.
8. Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A, de Belder MA: Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 2001;141:677-683.
9. Grines CL, Schreiber TL, Savas V, Jones DE, Zidar FJ, Gangadharan V, Brodsky M, Levin R, Safian R, Puchrowicz-Ochocki S, Castellani MD, O'Neill WW: A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. Circulation 2000;101:2172-2177.
10. Limbruno U, Petronio AS, Amoroso G, Baglini R, Paterni G, Merelli A, Mariotti R, De Caterina R, Mariani M: The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media. Circulation 2000;101:491-497.
11. Baim DS: Epinephrine: A new pharmacologic treatment for no-reflow? Catheter Cardiovasc Interv 2002;57:310-311.